SUVEN LIFE SCIENCES
Back to Balance Sheet
|
SUVEN LIFE SCIENCES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹19 Cr | ₹23 Cr | ₹14 Cr | ₹105 Cr | ₹102 Cr |
What is the latest Total Current Liabilities ratio of SUVEN LIFE SCIENCES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹19 Cr |
| Mar2025 | ₹23 Cr |
| Mar2024 | ₹14 Cr |
| Mar2023 | ₹105 Cr |
| Mar2022 | ₹102 Cr |
How is Total Current Liabilities of SUVEN LIFE SCIENCES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹19 Cr | -20.16 | |
| Mar2025 | ₹23 Cr | 73.76 | |
| Mar2024 | ₹14 Cr | -87.13 | |
| Mar2023 | ₹105 Cr | 2.75 | |
| Mar2022 | ₹102 Cr | - | |
Compare Total Current Liabilities of peers of SUVEN LIFE SCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUVEN LIFE SCIENCES | ₹7,398.5 Cr | -13.8% | -22.1% | 33.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,204.0 Cr | -1% | -5.5% | 5.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹238,497.0 Cr | -2.6% | -3.9% | 38.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹170,481.0 Cr | -1.7% | -10.2% | 30.5% | Stock Analytics | |
| CIPLA | ₹108,012.0 Cr | 0.9% | -3.2% | -15.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,207.0 Cr | -0.6% | 1% | -0.1% | Stock Analytics | |
SUVEN LIFE SCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUVEN LIFE SCIENCES | -13.8% |
-22.1% |
33.8% |
| SENSEX | -1.6% |
-2.3% |
-11.5% |
You may also like the below Video Courses